Clinical trial
Atorvastatin (Lipitor) to Prevent Bone Pain
NCT00120133 · Children's Mercy Hospital Kansas City, Other · Completed
Key facts
| NCT number | NCT00120133 |
|---|---|
| Title | Atorvastatin (Lipitor) to Prevent Bone Pain |
| Official title | Use of Atorvastatin (Lipitor) to Prevent Bone Pain Following Infusion of Pamidronate or Zoledronic Acid |
| Lead sponsor | Children's Mercy Hospital Kansas City, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | Atorvastatin |
| Enrollment | 12 |
| Start date | Dec 1, 2004 |
| Completion | Dec 1, 2007 |
| First posted | Jul 15, 2005 |
| Last update posted | May 20, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: